The inhibition of the 5-LOX pathway in the mantle cell lymphoma (MCL) cell line using zileuton and GSKi (FLAP inhibitor) decreased MCL cell migration towards CXCL12 (a ligand for the CXCR4 receptor) and reduced their stromal cell adhesion [31]. Here, CXCL12 is linked to mantle cell lymphoma.